135 related articles for article (PubMed ID: 17097963)
1. Posttransplant lymphoproliferative disease: a series of 23 cases.
Martín-Gómez MA; Peña M; Cabello M; Burgos D; Gutierrez C; Sola E; Acedo C; Bailén A; Gonzalez-Molina M
Transplant Proc; 2006 Oct; 38(8):2448-50. PubMed ID: 17097963
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
Shahinian VB; Muirhead N; Jevnikar AM; Leckie SH; Khakhar AK; Luke PP; Rizkalla KS; Hollomby DJ; House AA
Transplantation; 2003 Mar; 75(6):851-6. PubMed ID: 12660514
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
Birkeland SA; Hamilton-Dutoit S; Bendtzen K
Transplantation; 2003 Jul; 76(1):153-8. PubMed ID: 12865802
[TBL] [Abstract][Full Text] [Related]
5. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation.
Heo JS; Park JW; Lee KW; Lee SK; Joh JW; Kim SJ; Lee HH; Lee DS; Choi SH; Seo JM; Choe YH
Transplant Proc; 2004 Oct; 36(8):2307-8. PubMed ID: 15561231
[TBL] [Abstract][Full Text] [Related]
6. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
7. Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series.
Avolio AW; Agnes S; Barbarino R; Magalini SC; Frongillo F; Pagano L; Larocca LM; Pompili M; Caira M; Sollazzi L; Castagneto M
Transplant Proc; 2007; 39(6):1956-60. PubMed ID: 17692665
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
[TBL] [Abstract][Full Text] [Related]
9. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
[TBL] [Abstract][Full Text] [Related]
10. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center.
Quintini C; Kato T; Gaynor JJ; Ueno T; Selvaggi G; Gordon P; McLaughlin G; Tompson J; Ruiz P; Tzakis A
Transplant Proc; 2006; 38(6):1755-8. PubMed ID: 16908272
[TBL] [Abstract][Full Text] [Related]
11. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
Sundin M; Le Blanc K; Ringdén O; Barkholt L; Omazic B; Lergin C; Levitsky V; Remberger M
Haematologica; 2006 Aug; 91(8):1059-67. PubMed ID: 16885046
[TBL] [Abstract][Full Text] [Related]
12. Posttransplantation lymphoproliferative disorders in renal transplant recipients: report of over 20 years of experience.
Saadat A; Einollahi B; Ahmadzad-Asl MA; Moradi M; Nafar M; Pourfarziani V; Firoozan A; Porrezagholi F; Davoudi F
Transplant Proc; 2007 May; 39(4):1071-3. PubMed ID: 17524894
[TBL] [Abstract][Full Text] [Related]
13. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?
Birkeland SA; Hamilton-Dutoit S
Transplantation; 2003 Sep; 76(6):984-8. PubMed ID: 14508366
[TBL] [Abstract][Full Text] [Related]
14. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Roque J; Rios G; Humeres R; Volpi C; Herrera JM; Schultz M; Rios H; Rius M; Salgado C; Hepp J
Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation.
Taylor AL; Bowles KM; Callaghan CJ; Wimperis JZ; Grant JW; Marcus RE; Bradley JA
Transplantation; 2006 Aug; 82(3):375-81. PubMed ID: 16906036
[TBL] [Abstract][Full Text] [Related]
17. Incidence and consequences of post-transplantation lymphoproliferative disorders.
Boubenider S; Hiesse C; Goupy C; Kriaa F; Marchand S; Charpentier B
J Nephrol; 1997; 10(3):136-45. PubMed ID: 9238621
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years.
Abe T; Ichimaru N; Kokado Y; Maeda T; Kakuta Y; Okumi M; Imamura R; Nonomura N; Isaka Y; Takahara S; Okuyama A
Int J Urol; 2010 Jan; 17(1):48-54. PubMed ID: 20002504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
